|
gptkbp:instanceOf
|
gptkb:hormone
|
|
gptkbp:ATCCode
|
G03BA03
|
|
gptkbp:CASNumber
|
58-22-0
|
|
gptkbp:chemicalFormula
|
C19H28O2
|
|
gptkbp:class
|
gptkb:anabolic_steroid
gptkb:androgen
|
|
gptkbp:discoveredBy
|
gptkb:Ernst_Laqueur
|
|
gptkbp:discoveredIn
|
1935
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:foundIn
|
animals
humans
|
|
gptkbp:function
|
affects bone density
influences libido
influences muscle mass
regulates male secondary sexual characteristics
regulates sperm production
|
|
gptkbp:IUPACName
|
17β-hydroxyandrost-4-en-3-one
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
155 °C
|
|
gptkbp:MeSH_ID
|
D014 Testosterone
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
288.42 g/mol
|
|
gptkbp:predecessor
|
gptkb:estradiol
gptkb:dihydrotestosterone
|
|
gptkbp:producedBy
|
adrenal glands
ovaries
testes
|
|
gptkbp:PubChem_CID
|
gptkb:DB00624
6013
CHEMBL386630
|
|
gptkbp:relatedTo
|
gptkb:anabolic_steroids
gptkb:androgens
sex hormones
|
|
gptkbp:routeOfAdministration
|
oral
transdermal
intramuscular injection
|
|
gptkbp:sideEffect
|
hair loss
acne
gynecomastia
increased aggression
|
|
gptkbp:UNII
|
3XMK78S47O
|
|
gptkbp:usedFor
|
hormone replacement therapy
gender-affirming hormone therapy
treating hypogonadism
|
|
gptkbp:bfsParent
|
gptkb:Giorgos_Panousopoulos
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Testosteroni
|